1. FDA sees only slight dip in device approvals during pandemic — Novartis' Novartis to provide 'no profit' COVID drugs to low income countries — Relay Therapeutics prices IPO at $400M — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Knoll Pharmaceutical

Anonymous board for Knoll Pharmaceutical


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    37
    Views:
    15,399
  2. anonymous
    Replies:
    1
    Views:
    1,752
  3. Anonymous
    Replies:
    3
    Views:
    3,886
  4. Anonymous
    Replies:
    5
    Views:
    4,557

Thread Display Options

Loading...